Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 44, 2018 - Issue 4
Submit an article Journal homepage
91
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Equilibria, kinetics and mechanism for the degradation of the cytotoxic compound L-NG-nitroarginine

Pham Van QuyetGEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, National University of Singapore, Singapore, Singapore; View further author information
,
Bernice Mei Jin TanGEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, National University of Singapore, Singapore, Singapore; View further author information
,
Celine Valeria LiewGEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, National University of Singapore, Singapore, Singapore; View further author information
,
Lai Wah ChanGEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, National University of Singapore, Singapore, Singapore; View further author information
,
Quan Sing NgDivision of Medical Oncology, National Cancer Centre Singapore, Singapore, SingaporeView further author information
&
Paul Wan Sia HengGEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, National University of Singapore, Singapore, Singapore; Correspondence[email protected]
View further author information
Pages 624-631 | Received 03 Jun 2017, Accepted 08 Nov 2017, Published online: 04 Dec 2017

References

  • Chaplin DJ, Hill SA, Bell KM, et al. Modification of tumor blood flow: current status and future directions. Semin Radiat Oncol. 1998;8:151–163.
  • Pfeiffer S, Leopold E, Schmidt K, et al. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine. Br J Pharmacol. 1996;118:1433–1440.
  • Andrade SP, Hart IR, Piper PJ. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br J Pharmacol. 1992;107:1092–1095.
  • Wood PJ, Sansom JM, Butler SA, et al. Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-Nitro-L-arginine. Cancer Res. 1994;54:6458–6463.
  • Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res. 2004;21:201–230.
  • Hughes JP, Rees S, Kalindjian SB, et al. Principles of early drug discovery. Br J Pharmacol. 2011;162:1239–1249.
  • Boquet MP, Wagner DR. Injectable formulations of poorly water-soluble drugs. In: Williams RO, Watts AB, Miller DA, editors. Formulating poorly water soluble drugs. New York (NY): Springer; 2012. p. 209–242.
  • Simamora P, Pinsuwan S, Alvarez JM, et al. Effect of pH on injection phlebitis. J Pharm Sci. 1995;84:520–522.
  • Gerry S. Preformulation as an aid to product design in early drug development. In: Gibson M, editor. Pharmaceutical preformulation and formulation. United Kingdom: CRC Press; 2009. p. 188–246.
  • Loudon GM. Mechanistic interpretation of pH-rate profiles. J Chem Educ. 1991;68:973.
  • Qandil AM, Jamhawi NM, Tashtoush BM, et al. The hydrolysis kinetics of monobasic and dibasic aminoalkyl esters of ketorolac. Drug Dev Ind Pharm. 2013;39:1346–1356.
  • Yeh MK. Degradation kinetics of neostigmine in solution. Drug Dev Ind Pharm. 2000;26:1221–1226.
  • Gu L, Dunn J, Dvorak C. Preformulation prodrug research–chemical and enzymatic hydrolysis kinetics of the glycerol, glycolic acid and morpholino ethyl ester derivatives of a developmental analgesic agent (RS-82917). Drug Dev Ind Pharm. 1989;15:209–221.
  • Angelov T, Vlasenko A, Tashkov W. HPLC determination of pKa of parabens and investigation on their lipophilicity parameters. J Liq Chromatogr Relat Technol. 2007;31:188–197.
  • Chapter 27: amino acids, peptides and proteins [Internet]. USA: F. A. Carey; [cited 2017 Oct 12]. Available from: http://www.mhhe.com/physsci/chemistry/carey5e/Ch27/ch27-1-4-2.html
  • Košturiak A, Zacharová-Kálavska D. Study of the hydrolysis of the C = N bond in 3-phenyliminoxindol. Chem Pap. 1975;29:34–38.
  • Canneaux S, Hammaecher C, Louis F, et al. Rate constant calculation of benzylperoxy radical isomerization. In: Han K, Chu T, editors. Reaction rate constant computations: theories and applications. United Kingdom: The Royal Society of Chemistry; 2013. p. 34–54.
  • Hao AJ, Deng YJ, Li TF, et al. Degradation kinetics of fluorouracil-acetic-acid-dextran conjugate in aqueous solution. Drug Dev Ind Pharm. 2006;32:757–763.
  • Herrmann J, Bodmeier R. Degradation kinetics of somatostatin in aqueous solution. Drug Dev Ind Pharm. 2003;29:1027–1033.
  • Suleiman MS, Abdulhameed ME, Najib NM, et al. Degradation kinetics of diltiazem. Drug Dev Ind Pharm. 1990;16:685–694.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.